カテゴリー： 世界, 医療/バイオ, IMARC

世界のワクチン受託製造市場予測2023年-2028年

【英語タイトル】Vaccine Contract Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが出版した調査資料（IMARC23DCB0314）・商品コード：IMARC23DCB0314
・発行会社（調査会社）：IMARC
・発行日：2023年11月
・ページ数：147
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

世界のワクチン受託製造市場は2022年に25億ドルに達しました。今後、IMARC Groupは、2022年から2028年にかけて10.3%の成長率（CAGR）を示し、2028年には45億ドルに達すると予測しています。
ワクチン受託製造とは、ワクチンの大量生産を製造受託機関（CMO）に委託することです。これらの組織は、プレフォーミュレーション業務、製剤開発、製法開発、安定性試験、前臨床活動、登録バッチ、商業製造を含む数多くのサービスを提供しています。これとは別に、製薬会社の生産チェーンを拡大するための専門知識や革新的な技術も提供しています。現在、開発コストの削減と複雑な製造プロトコルを理由に、ワクチン製造業務のアウトソーシングに対する需要が世界中で高まっています。

ワクチン接種は、動物だけでなく人間の健康増進にも極めて重要な役割を果たしています。抗生物質の必要性を減らし、病気を予防します。ワクチン接種に対する意識の高まりと、重篤な病気や感染症から身を守るといった多くの関連メリットが、予防接種プログラムや予防接種の需要を喚起しています。このことは、製造に必要な資本の複雑さを理解することと相まって、大手製薬会社をワクチン製造のアウトソーシングへと導いています。これとは別に、低資源国におけるワクチン製造のための設備や熟練労働者の不足も、世界のワクチン受託製造市場の成長に寄与しています。さらに、EB66やGPExのような発現システムや細胞培養培地プラットフォームの導入を含む技術的進歩が、市場の成長を支えています。さらに、多くの国々でコロナウイルス感染症（COVID-19）の症例が憂慮すべきほど増加していることから、ワクチン開発企業はCMOと業務委託契約を結ぶようになりましました。このため、市場成長の見通しは良好です。

主な市場セグメンテーション
IMARC Groupは、世界のワクチン受託製造市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、ワクチンタイプ、ワークフロー、アプリケーションに基づいて市場を分類しています。

ワクチンタイプ別
弱毒化
不活化
サブユニットベース
トキソイドベース
DNAベース

ワークフロー別

ダウンストリーム
充填および仕上げ作業
分析およびQC研究
パッケージング
アップストリーム
哺乳類発現システム
細菌発現システム
酵母発現システム
バキュロウイルス/昆虫発現システム
その他

用途別
ヒト用
動物用

地域別
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争状況
業界の競争環境は、味の素株式会社、Albany Molecular Research Inc.、Catalent Inc.、Cobra Biologics Limited (Charles River Laboratories International Inc.)、Cytovance Biologics Inc. (Hepalink USA Inc.)、Fujifilm Holdings Corporation、ICON plc、IDT Biologika GmbH、Lonza Group AG、Merck KGaA、Pharmaceutical Product Development LLC、PRA Health Sciences Inc.などの主要企業のプロフィールとともに調査されています。

本レポートで扱う主な質問
世界のワクチン受託製造市場はこれまでどのように推移してきたか？
COVID-19が世界のワクチン受託製造市場に与えた影響は？
主要な地域市場は？
ワクチンの種類に基づく市場の内訳は？
ワークフローに基づく市場の内訳は？
アプリケーションに基づく市場の内訳は？
業界のバリューチェーンにおける様々な段階とは？
業界の主要な推進要因と課題は何ですか？
世界のワクチン受託製造市場の構造と主要プレーヤーは？
業界における競争の程度は？

1. 序論
2. 範囲・調査手法
3. エグゼクティブサマリー
4. イントロダクション
5. 世界のワクチン受託製造市場
6. ワクチン受託製造の世界市場規模：ワクチンタイプ別
7. ワクチン受託製造の世界市場規模：ワークフロー別
8. ワクチン受託製造の世界市場規模：用途別
9. ワクチン受託製造の世界市場規模：地域別
10. SWOT分析
11. バリューチェーン分析
12. ファイブフォース分析
13. 価格分析
14. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Vaccine Contract Manufacturing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 Attenuated
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Inactivated
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Subunit-based
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Toxoid-based
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 DNA-based
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Workflow
7.1 Downstream
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Fill and Finish Operations
7.1.2.2 Analytical and QC studies
7.1.2.3 Packaging
7.1.3 Market Forecast
7.2 Upstream
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Mammalian Expression Systems
7.2.2.2 Bacterial Expression Systems
7.2.2.3 Yeast Expression Systems
7.2.2.4 Baculovirus/Insect Expression Systems
7.2.2.5 Others
7.2.3 Market Forecast
8 Market Breakup by Application
8.1 Human Use
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Veterinary
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Ajinomoto Co. Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Albany Molecular Research Inc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Catalent Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Cobra Biologics Limited (Charles River Laboratories International Inc.)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Cytovance Biologics Inc. (Hepalink USA Inc.)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Fujifilm Holdings Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 ICON plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 IDT Biologika GmbH
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Lonza Group AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Merck KGaA
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Pharmaceutical Product Development LLC
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 PRA Health Sciences Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials

Figure 1: Global: Vaccine Contract Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Vaccine Contract Manufacturing Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Vaccine Contract Manufacturing Market: Breakup by Vaccine Type (in %), 2022
Figure 5: Global: Vaccine Contract Manufacturing Market: Breakup by Workflow (in %), 2022
Figure 6: Global: Vaccine Contract Manufacturing Market: Breakup by Application (in %), 2022
Figure 7: Global: Vaccine Contract Manufacturing Market: Breakup by Region (in %), 2022
Figure 8: Global: Vaccine Contract Manufacturing (Attenuated) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Vaccine Contract Manufacturing (Attenuated) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Vaccine Contract Manufacturing (Inactivated) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Vaccine Contract Manufacturing (Inactivated) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Vaccine Contract Manufacturing (Subunit-based) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Vaccine Contract Manufacturing (Subunit-based) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Vaccine Contract Manufacturing (Toxoid-based) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Vaccine Contract Manufacturing (Toxoid-based) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Vaccine Contract Manufacturing (DNA-based) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Vaccine Contract Manufacturing (DNA-based) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Vaccine Contract Manufacturing (Downstream) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Vaccine Contract Manufacturing (Downstream) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Vaccine Contract Manufacturing (Upstream) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Vaccine Contract Manufacturing (Upstream) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Vaccine Contract Manufacturing (Human Use) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Vaccine Contract Manufacturing (Human Use) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Vaccine Contract Manufacturing (Veterinary) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Vaccine Contract Manufacturing (Veterinary) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: North America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: United States: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: United States: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Canada: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Canada: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Asia-Pacific: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Asia-Pacific: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: China: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: China: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Japan: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Japan: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: India: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: India: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: South Korea: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: South Korea: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Australia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Australia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Indonesia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Indonesia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Europe: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Europe: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Germany: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Germany: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: France: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: France: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United Kingdom: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United Kingdom: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Italy: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Italy: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Spain: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Spain: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Russia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Russia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Latin America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Latin America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Brazil: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Brazil: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Mexico: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Mexico: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Middle East and Africa: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Middle East and Africa: Vaccine Contract Manufacturing Market: Breakup by Country (in %), 2022
Figure 74: Middle East and Africa: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Global: Vaccine Contract Manufacturing Industry: SWOT Analysis
Figure 76: Global: Vaccine Contract Manufacturing Industry: Value Chain Analysis
Figure 77: Global: Vaccine Contract Manufacturing Industry: Porter's Five Forces Analysis

Table 1: Global: Vaccine Contract Manufacturing Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
Table 3: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Workflow (in Million US$), 2023-2028
Table 4: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Vaccine Contract Manufacturing Market: Competitive Structure
Table 7: Global: Vaccine Contract Manufacturing Market: Key Players

★調査レポート[世界のワクチン受託製造市場予測2023年-2028年] (コード：IMARC23DCB0314)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のワクチン受託製造市場予測2023年-2028年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のタンパク質発現市場予測2022年-2028年
  • 世界の無細胞タンパク質発現市場予測2023年-2028年
  • 世界のプロテオミクス市場予測2023年-2028年
  • 世界のマンモグラフィ市場予測2023年-2028年
  • 世界のインターベンショナル放射線学市場予測2023年-2028年
  • 世界のモノクローナル抗体市場予測2022年-2028年
  • 世界の非黒色腫皮膚がん治療市場予測2023年-2028年

    • ◆H&Iグローバルリサーチのお客様（例）◆